Dr Stuart Sims

Industry Partnerships and Commercialisation Executive, Natural Sciences

Dr Stuart sims is Industry Partnerships and Commercialisation Executive in the Faculty of Natural Sciences at Imperial College London

Stuart's portfolio

Aptamer-based multiplex screening platform

Aptamer-based multiplex screening platform

A fully flexible, scalable and low-cost detection platform to sense multiple protein targets simultaneously by grafting specific sequences along the backbone of a double-stranded DNA carrier. Find out more

DEP Trapping Using Metallised Nanopipettes

DEP Trapping Using Metallised Nanopipettes

This invention enables efficient single molecule nanopore sensing at femtomolar concentrations using dielectrophoretic trapping by combining nanopore sensing and dielectrophoresis (DEP). Find out more

Nanotweezers for single-cell biopsy

Nanotweezers for single-cell biopsy

Inexpensive, easy to fabricate and use, dielectrophoretic nanotweezers for non-destructive subcellular concentration (trapping) and extraction of biomolecules. Find out more

Hybrid nanopore opto-electronic platform for single molecule biological screening

Hybrid nanopore opto-electronic platform for single molecule biological screening

A molecular beacon-modified DNA carrier to specifically identify short nucleic acids and small proteins using a synchronised opto-electronic platform with nanopipette. Find out more

A novel dimer system for single small molecule detection

A novel dimer system for single small molecule detection

A new method for the efficient and accurate detection of proteins with nanopores by utilising aptamer-modified gold nanoparticle (AuNP) Find out more

Novel vortex laser

Novel vortex laser

A high-power and high-efficiency new methodology for laser vortex creation that enables new devices and applications with vortex spatial format. Find out more

Novel inhibitor of neuropathic pain

Novel inhibitor of neuropathic pain

This novel neutralising antibody-based approach offers an innovative and valuable therapeutic strategy for patients with neuropathic pain. Find out more

Sign up for updates

Sign up for monthly technology alerts via email, and find other ways to connect with us.

Loading...